BRAF mutation testing for patients diagnosed with stage III or stage IV melanoma: practical guidance for the Australian setting

- Scolyer, Richard A., Atkinson, Victoria, Ch'ng, Sydney, Colebatch, Andrew J., Daneshvar, Dariush, Pires da Silva, Ines, Dawson, Tamara, Ferguson, Peter M., Foster-Smith, Erwin, Fox, Stephen B., Gill, Anthony J., Gupta, Ruta, Gyorki, David E., Henderson, MA, Hong, AM, Howle, JR, Jackett, LA, James, C, Lee, CS, Lochhead, A, Loh, D, McArthur, GA, McLean, CA, Lambie, Duncan, Menzies, AM, Nieweg, OE, O'Brien, BH, Pennington, TE, Potter, AJ, Prakash, S, Rawson, RV, Read, RL, Rtshiladze, MA, Shannon, KF, O'Toole, Sandra, Smithers, BM, Spillane, AJ, Stretch, JR, Thompson, JF, Tucker, P, Varey, AHR, Vilain, Ricardo E., Wood, BA, Long, GV, Saw, Robyn P. M., Amanuel, Benhur, Angel, Christopher M., Button-Sloan, Alison E., Carlino, Matteo S.

KRAS mutation testing of metastatic colorectal cancer in Australia: where are we at?

- Scott, Rodney J., Fox, Stephen B., Byron, Keith, Rudzki, Barney, Waring, Paul, Iacopetta, Barry, Desai, Jayesh, Grieu, Fabienne, Amanuel, Benhur, Garrett, Kerryn, Harraway, James, Cheetham, Glenice, Pattle, Neville, Haddad, Afaf